Levels of antihemophilic factor were below 50 per cent in 5 patients and low normal (54 per cent and 65 per cent) in the other 2 hypothyroid patients. The mean level was 44 ± 4.3 per cent ...

AFSTYLA ®, Antihemophilic Factor (Recombinant), Single Chain, is contraindicated in patients who have had life-threatening hypersensitivity reactions to AFSTYLA or its excipients, or to hamster ...

Antihemophilic Factor VIII (human) 250 IU, 500 IU, 1000 IU; per bottle; dried concentrate for IV infusion after reconstitution; contains albumin. Dosage Required (IU) = Body Weight (kg ...

Antihemophilic Factor VIII/Von Willebrand Factor Complex (human) 250 IU FVIII + 600 IU VWF, 500 IU FVIII + 1200 IU VWF, 1000 IU FVIII + 2400 IU VWF; per vial; lyophilized pwd for IV infusion after ...

NEW DELHI: The Delhi high court has directed the Centre and the Delhi government to file comprehensive reports on the availability and supply chain management of Antihemophilic Factor (AHF ...

The indications, pharmacokinetics, and therapeutic guidelines for available coagulation products are reviewed. Patients with hemophilia, von Wille-brand's disease (VWD), or acquired inhibitors to ...

Key data to be presented at WFH 2025 Comprehensive Care Summit, Dubai, UAE Altuvoct® (efanesoctocog alfa) Location: Great Ballroom .